Investors are intensively searching for and showing immense interest in 3M Company (MMM). Analysts are recommending different strategies for playing the 3M stock, especially with the upcoming Q1 earnings. The company's Q1 2024 earnings call transcript reveals information on 3M’s operational performance and financial direction.
Reports indicate mixed reviews on the company's stock worth, with some suggesting the stock as overrated and others noting its strong momentum. The stock has shown fluctuations with instances of both surpassing and lagging behind the market. This dynamic has led to speculation if the company can double in five years.
Recent executive changes include the appointment of William Brown as CEO. 3M has also announced plans of a healthcare business spin-off, Solventum, broadening the company's profile. The Solventum unit will be spun off tax-free to shareholders.
Analysts at Vertical Research have upgraded the company, evaluating it as a 'Buy'. The company's stock has periodically outperformed the broader market apart from a few declines. The impending cut in dividend post healthcare spinoff has sparked varied responses. Finally, the company's full-year 2024 guidance met with slight disappointment causing the stock to slide.
3m Company MMM News Analytics from Thu, 16 Nov 2023 08:00:00 GMT to Tue, 21 May 2024 12:32:04 GMT - Rating 2 - Innovation -2 - Information 6 - Rumor -4
